events

CABC Seminar: "Tobacco use pharmacotherapy - innovative approaches to real world situations"

James Davis MD
 - 

contact

Vahaba, Daniel

919-613-5014

event sponsored by

Duke Institute for Brain Sciences (DIBS) &

Center for the Study of Adolescent Risk and Resilience (C-StARR), Center on Addiction and Behavior Change, and Department of Psychiatry and Behavioral Sciences

series

CABC Seminar Series


speaker

James Davis, MD (Duke University)

Dr. James Davis is a practicing physician of Internal Medicine, and serves as the Medical Director for Duke Center for Smoking Cessation, Director of the Duke Smoking Cessation Program and Co-Director of the Duke-UNC Tobacco Treatment Specialist Credentialing Program. His research focuses on development of new pharmaceutical treatments for smoking cessation. He is principal investigator on several trials including a study on "adaptive" smoking cessation and several trials on new medications for smoking cessation. The new medications leverage more novel neurobiological mechanisms - NMDA receptor antagonism, nicotinic receptor antagonism, which impact addiction-based learning and cue response. Additionally, Dr. Davis serves as co-investigator on trials on lung cancer screening, e-cigarettes, minor nicotine alkaloids, imaging trials, lung function trials and others. Dr. Davis leads the Duke Smoke-Free Policy Initiative, is co-author on a national tobacco dependence treatment guideline, and provides training in tobacco dependence treatment for the Duke School of Medicine, Duke Internal Medicine, Family Practice and Psychiatry residency programs.

Categories

Medicine, Natural Sciences, Health/Wellness, Lecture/Talk, Panel/Seminar/Colloquium, and Research